At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Controlled, Open-label, 3-arm Parallel Group, Single-center Study to Demonstrate Reductions in Exposure to Selected Smoke Constituents in Smoking, Healthy Subjects Switching to the Tobacco Heating System 2.2 (THS 2.2) or Smoking Abstinence, Compared to Continuing to Use Conventional Cigarettes, for 5 Days in Confinement.
In Brief
A clinical study evaluating Tobacco Heating System (THS 2.2), Smoking abstinence (SA), and 1 other intervention for Smoking. Completed, enrolled 169 participants across 1 site.
Detailed Summary
The overall goal of the study is to evaluate if the ad libitum use of the Tobacco Heating System 2.2 (THS 2.2) for 5 days by adult healthy smokers results in a reduction in the levels of biomarkers of exposure (BoExp) for selected harmful and potentially harmful constituents (HPHCs) compared to smoking conventional cigarettes (CC) and smoking abstinence (SA).
Study Details
Timeline
Interventions
THS 2.2 ad libitum for 5 days in confinement
SA for 5 days in confinement
Subject's own preferred brand of CC ad libitum for 5 days in confinement